PSA launches hormonal contraceptive prescribing training for Queensland pharmacists

Queensland pharmacists participating in the Queensland Community Pharmacy Hormonal Contraception Pilot can now enrol in the Sexual and Reproductive Health Contraceptive Service – Queensland training program launched by the Pharmaceutical Society of Australia (PSA) today.

Completion of the course allows pharmacists to autonomously prescribe hormonal contraception for female patients aged 16 years and older under the Pilot.

PSA’s training program features cutting-edge AI technology, allowing pharmacists to engage with a virtual patient in a simulated consultation to build confidence and competence in prescribing.

PSA General Manager – Education and Training Kerri Barwick encouraged pharmacists to undertake training to deliver contraception prescribing services.

“This new training initiative is an important step forward in supporting the role of pharmacists in reproductive health,” Ms Barwick said.

“Pharmacists prescribing hormonal contraception will mean more accessible care for Queensland women, putting patient care first and ensuring safe and effective contraception options are available when and where they’re needed.

“PSA’s training program is one of the first to utilise artificial intelligence, giving pharmacists the opportunity to test their skills in a simulated clinical environment. We’re excited to continue to innovate how we deliver nation-leading education to Australian pharmacists.

“PSA continues to work closely with the Queensland Government to deliver training and education to pharmacists as part of the Queensland community pharmacy pilots. On behalf of PSA, we again commend the Queensland Government for implementing the most progressive scope of practice pilot in the country.”

The Sexual and Reproductive Health Contraceptive Service – Queensland is open for enrolments now.

Must Read

New regional roadmaps for prioritising antimicrobial resistance

0
A new publication by the International Pharmaceutical Federation (FIP) identifies priority actions pharmacists should take to minimise antimicrobial resistance (AMR). The publication presents six...